Association of CD27 and CD70 gene polymorphisms with risk of sporadic breast cancer in Chinese women in Heilongjiang Province

Breast Cancer Research and Treatment

Volumn 133, Issue 3, 2012, Pages 1105-1113

  Xu, Fengyan ^a   Li, Dalin ^a   Zhang, Qiujin ^a   Fu, Zhenkun ^a   Yuan, Weiguang ^a   Pang, Da ^a   Li, Dianjun ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; CD27; CD70; Haplotype; Polymorphism

Indexed keywords

ADENINE; CD27 ANTIGEN; CD70 ANTIGEN; CYTOSINE; ESTROGEN RECEPTOR; GUANINE; PROGESTERONE RECEPTOR; THYMINE;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CD27 GENE; CD70 GENE; CHINESE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC CODE; GENOTYPE; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE;

ADULT; ANTIGENS, CD27; ANTIGENS, CD70; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK;

EID: 84863719885     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-1987-7     Document Type: Article

References (33)

1. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R et al (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447(7148):1087-1093
2. DeNardo DG, Coussens LM (2007) Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res 9(4):212
3. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3:991-998
4. Disis ML, Park KH (2009) Immunomodulation of breast cancer via tumor antigen specific Th1. Cancer Res Treat 41(3):117-121
5. Whiteside TL (2010) Immune responses to malignancies. J Allergy Clin Immunol 125:S272-S283
6. Inman BA, Frigola X, Dong H, Kwon ED (2007) Costimulation, coinhibition and cancer. Curr Cancer Drug Target 7(1):15-30
7. Ghaderi A, Yeganeh F, Kalantari T, Talei AR, Pezeshki AM, Doroudchi M, Dehaghani AS (2004) Cytotoxic T lymphocyte antigen-4 gene in breast cancer. Breast Cancer Res Treat 86(1):1-7
8. Hua Z, Li D, Xiang G, Xu F, Jie G, Fu Z, Jie Z, Da P, Li D (2011) PD-1 polymorphisms are associated with sporadic breast cancer in Chinese Han population of Northeast China. Breast Cancer Res Treat 129(1):195-201
9. Akiba H, Nakano H, Nishinaka S, Shindo M, Kobata T, Atsuta M, Morimoto C, Ware CF, Malinin NL, Wallach D et al (1998) CD27, a member of the tumor necrosis factor receptor super-family, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase. J Biol Chem 273(21):13353-13358
10. Gravestein LA, Amsen D, Boes M, Calvo CR, Kruisbeek AM, Borst J (1998) The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2. Eur J Immunol 28(7):2208-2216
11. Lens SM, Tesselaar K, van Oers MH, van Lier RA (1998) Control of lymphocyte function through CD27-CD70 interactions. Semin Immunol 10(6):491-499
12. Takeda K, Oshima H, Hayakawa Y, Akiba H, Atsuta M, Kobata T, Kobayashi K, Ito M, Yagita H, Okumura K (2000) CD27-mediated activation of murine NK cells. J Immunol 164(4):1741-1745
13. Arens R, Tesselaar K, Baars PA, van Schijndel GM, Hendriks J, Pals ST, Krimpenfort P, Borst J, van Oers MH, van Lier RA (2001) Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFN gamma-mediated B cell depletion. Immunity 15(5):801-812
14. Keller AM, Schildknecht A, Xiao Y, van den Broek M, Borst J (2008) Expression of costimulatory ligand CD70 on steady-state dendritic cells breaks CD8? T cell tolerance and permits effective immunity. Immunity 29(6):934-946
15. Arens R, Schepers K, Nolte MA, van Oosterwijk MF, van Lier RA, Schumacher TN, van Oers MH (2004) Tumor rejection induced by CD70-mediated quantitative and qualitative effects on effector CD8? T cell formation. J Exp Med 199(11):1595-1605
16. Laouar A, Haridas V, Vargas D, Zhinan X, Chaplin D, van Lier RA, Manjunath N (2005) CD70? antigen-presenting cells control the proliferation and differentiation of T cells in the intestinal mucosa. Nat Immunol 6(7):698-706
17. Peperzak V, Xiao Y, Veraar EA, Borst J (2010) CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production. J Clin Invest 120(1):168-178
18. Kelly JM, Darcy PK, Markby JL, Godfrey DI, Takeda K, Yagita H, Smyth MJ (2002) Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat Immunol 3(1):83-90
19. Nieland JD, Graus YF, Dortmans YE, Kremers BL, Kruisbeek AM (1998) CD40 and CD70 co-stimulate a potent in vivo antitumor T cell response. J Immunother 21(3):225-236
20. Yu SE, Park SH, Jang YK (2010) Epigenetic silencing of TNFSF7 (CD70) by DNA methylation during progression to breast cancer. Mol Cells 29(2):217-221
21. Rahimifar S, Erfani N, Sarraf Z, Ghaderi A (2010) ctla-4 gene variations may influence cervical cancer susceptibility. Gynecol Oncol 119(1):136-139
22. Cheng TY, Lin JT, Chen LT, Shun CT, Wang HP, Lin MT, Wang TE, Cheng AL, Wu MS (2006) Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-asso-ciated lymphoid tissue lymphoma susceptibility. J Clin Oncol 24(21):3483-3489
23. Suwalska K, Pawlak E, Karabon L, Tomkiewicz A, Dobosz T, Urbaniak-Kujda D, Kuliczkowski K, Wolowiec D, Jedynak A, Frydecka I (2008) Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population. Hum Immunol 69(3):193-201
24. Hendriks J, Gravestein LA, Tesselaar K, van Lier RA, Schumacher TN, Borst J (2000) CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol 5:433-440
25. Orengo AM, Cantoni C, Neglia F, Biassoni R, Ferrini S (1997) Reciprocal expression of CD70 and of its receptor, CD27, in human long term-activated T and natural killer (NK) cells: inverse regulation by cytokines and role in induction of cyto-toxicity. Clin Exp Immunol 107(3):608-613
26. Balvay L, Libri D, Fiszman MY (1993) Pre-mRNA secondary structure and the regulation of splicing. Bioessays 15(3):165-169
27. Majewski J, Ott J (2002) Distribution and characterization of regulatory elements in the human genome. Genome Res 12(12): 1827-1836
28. Baralle D, Baralle M (2005) Splicing in action: assessing disease causing sequence changes. J Med Genet 42(10):737-748
29. Borst J, Hendriks J, Xiao Y (2005) CD27 and CD70 in T cell and B cell activation. Curr Opin Immunol 17(3):275-281
30. Cormary C, Gonzalez R, Faye JC, Favre G, Tilkin-Mariame AF (2004) Induction of T-cell antitumor immunity and protection against tumor growth by secretion of soluble human CD70 molecules. Cancer Gene Ther 11(7):497-507
31. Capon F, Allen MH, Ameen M, Burden AD, Tillman D, Barker JN, Trembath RC (2004) A synonymous SNP of the corne-odesmosin gene leads to increased mRNA stability and demonstrates association with psoriasis across diverse ethnic groups. Hum Mol Genet 13(20):2361-2368
32. Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Kor-chynskyi O, Makarov SS, Maixner W, Diatchenko L (2006) Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 314(5807):1930-1933
33. Nielsen KB, Sorensen S, Cartegni L, Corydon TJ, Doktor TK, Schroeder LD, Reinert LS, Elpeleg O, Krainer AR, Gregersen N et al (2007) Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: asynonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer. Am J Hum Genet 80(3):416-432